YAP1 amplification as a prognostic factor of definitive chemoradiotherapy in nonsurgical esophageal squamous cell carcinoma

YAP1 amplification as a prognostic factor of definitive chemoradiotherapy in nonsurgical esophageal squamous cell carcinoma

Abstract Background Definitive chemoradiation therapy (dCRT) is the standard treatment for patients with nonsurgical esophageal squamous cell carcinoma (ESCC), yet patients have demonstrated great variations in their responses to dCRT and inevitably progressed following treatment. Methods To identif...

Full description

Bibliographic Details
Main Authors:	Honghai Dai, Yang W. Shao, Xiaoling Tong, Xue Wu, Jiaohui Pang, Alei Feng, Zhe Yang
Format:	Article
Language:	English
Published:	Wiley 2020-03-01
Series:	Cancer Medicine
Subjects:	chemoradiation therapy esophageal squamous cell carcinoma local recurrence‐free survival next‐generation sequencing YAP1 amplification
Online Access:	https://doi.org/10.1002/cam4.2761

Similar Items

Neoadjuvant chemoradiotherapy for thoracic esophageal squamous cell carcinoma: does everyone need it?
by: D. A. Chichevatov, et al.
Published: (2024-05-01)

Definitive Chemoradiation with Concurrent Weekly Cisplatin in the Treatment of Esophageal Squamous Cell Carcinoma – A Simplistic Approach
by: Imtiaz Ahmed, et al.
Published: (2021-05-01)

The efficacy and safety of definitive concurrent chemoradiotherapy for non‐operable esophageal cancer
by: Alexandra D. Dreyfuss, et al.
Published: (2021-02-01)

Change in PD-L1 and CD8 Expression after Chemoradiotherapy for Esophageal Squamous Cell Carcinoma
by: Wei-Chung Chen, et al.
Published: (2022-08-01)

Current and future on definitive concurrent chemoradiotherapy for inoperable locally advanced esophageal squamous cell carcinoma
by: Renxian Xie, et al.
Published: (2024-01-01)

Successful extirpation of a perforated esophagus after chemo radiotherapy in infiltrative ulcerative squamous cell carcinoma
by: T. S. Rogova, et al.
Published: (2023-06-01)

Immunotherapy Plus Chemoradiation Improves Overall Survival in Stage IV Esophageal Cancer: A Cohort Study
by: Saber Amin, et al.
Published: (2024-01-01)

Comparison of the Clinical Outcomes of Esophagectomy and Concurrent Chemoradiotherapy in Patients with Locally Advanced Esophageal Squamous Cell Carcinoma
by: Myung Hun Lee, et al.
Published: (2024-03-01)

Radiotherapy and chemoradiotherapy for postoperative recurrence in patients with esophageal squamous cell carcinoma
by: Qing Liu, et al.
Published: (2024-08-01)

Treatment of cervical esophageal carcinoma: systematic review and meta-analysis
by: D. A. Chichevatov, et al.
Published: (2023-09-01)

Comparison of neoadjuvant chemotherapy or chemoradiotherapy plus immunotherapy for locally resectable esophageal squamous cell carcinoma
by: Guozhen Yang, et al.
Published: (2024-05-01)

USP14 inhibition by degrasyn induces YAP1 degradation and suppresses the progression of radioresistant esophageal cancer
by: Fang Yuan, et al.
Published: (2025-02-01)

Results of combined and chemoradiation treatment of patients with thoracic esophageal cancer according to the data of the regional cancer center
by: E. A. Toneev, et al.
Published: (2023-11-01)

Prognostic role of the pathological status following neoadjuvant chemoradiotherapy and surgery in esophageal squamous cell carcinoma
by: Xiaofeng Duan, et al.
Published: (2025-01-01)

Definitive chemoradiotherapy with paclitaxel for locally advanced esophageal squamous cell carcinoma in older patients (PARADISE-1): a phase I trial
by: Kenro Hirata, et al.
Published: (2024-07-01)

Changes in PD-1 expression on T lymphocyte subsets and related immune indicators before and after definitive chemoradiotherapy for esophageal squamous cell carcinoma
by: Xueling Shi, et al.
Published: (2025-12-01)

Consolidation chemotherapy after definitive concurrent chemoradiotherapy in patients with inoperable esophageal squamous cell carcinoma: a multicenter non-inferiority phase III randomized clinical trial
by: Chengcheng Fan, et al.
Published: (2024-03-01)

Number of Retrieved Lymph Nodes during Esophagectomy Affects the Outcome of Stage III Esophageal Cancer in Patients Having Had Pre-Operative Chemo-Radiation Therapy
by: Wei Ho, et al.
Published: (2024-09-01)

Salivary microbiome is associated with the response to chemoradiotherapy in initially inoperable patients with esophageal squamous cell carcinoma
by: Yuan He, et al.
Published: (2024-12-01)

Comparative transcriptome characterization of esophageal squamous cell carcinoma and adenocarcinoma
by: Xianfeng Li, et al.
Published: (2023-01-01)

Immune checkpoint inhibitors combined with concurrent chemoradiotherapy in locally advanced esophageal squamous cell carcinoma
by: Jiang-Qiong Huang, et al.
Published: (2024-03-01)

Prognostic value of sarcopenia and inflammatory indices synergy in patients with esophageal squamous cell carcinoma undergoing chemoradiotherapy
by: Ling Xiao, et al.
Published: (2024-07-01)

Nomogram for predicting pathologic complete response to neoadjuvant chemoradiotherapy in patients with esophageal squamous cell carcinoma
by: Guihong Liu, et al.
Published: (2024-03-01)

Genomic, transcriptomic, and T cell receptor profiling in stratifying response to first-line chemoradiotherapy or radiotherapy for esophageal squamous cell carcinoma
by: Xiaqin Zhang, et al.
Published: (2025-01-01)

The prognostic role of pre-treatment neutrophil to lymphocyte ratio and platelet to lymphocyte ratio in esophageal squamous cell carcinoma treated with concurrent chemoradiotherapy
by: Qirong Man, et al.
Published: (2024-04-01)

The significance of consolidation chemotherapy after concurrent chemoradiotherapy in esophageal squamous cell carcinoma: a randomized controlled phase III clinical trial
by: Qingshan Zhu, et al.
Published: (2024-10-01)

Neoadjuvant chemoimmunotherapy was associated with better short‐term survival of patients with locally advanced esophageal squamous cell carcinoma compared to neoadjuvant chemoradiotherapy
by: Xiaofeng Duan, et al.
Published: (2024-08-01)

Prognosis of Pneumonia in Head and Neck Squamous Cell Carcinoma Patients Who Received Concurrent Chemoradiotherapy
by: Tzu-Hsun Kao, et al.
Published: (2024-07-01)

SOX2 antagonizes WWC1 to drive YAP1 activation in esophageal squamous cell carcinoma
by: Yuhang Chai, et al.
Published: (2019-11-01)

Identification of key genes to predict response to chemoradiotherapy and prognosis in esophageal squamous cell carcinoma
by: Yingying Cui, et al.
Published: (2024-11-01)

Esophageal squamous cell carcinoma with EP300 mutations displays distinct genetic characteristics relevant to neoadjuvant chemoradiotherapy
by: Yutian Lai, et al.
Published: (2025-01-01)

A CT-based subregional radiomics nomogram for predicting local recurrence-free survival in esophageal squamous cell cancer patients treated by definitive chemoradiotherapy: a multicenter study
by: Jie Gong, et al.
Published: (2024-12-01)

Neoadjuvant radiation target volume definition in esophageal squamous cell cancer: a multicenter recommendations from Chinese experts
by: Dan Han, et al.
Published: (2024-09-01)

Association between serum levels of 12 different cytokines and short-term efficacy of chemoradiotherapy in esophageal squamous cell carcinoma
by: Yaping Zhang, et al.
Published: (2025-01-01)

Sarcopenia Before Concurrent Chemoradiotherapy May Develop Severe Adverse Reactions in Patients with Esophageal Squamous Cell Carcinoma
by: CHEN Xiaoxia, et al.
Published: (2023-12-01)

Clinical outcomes of esophageal squamous cell carcinoma in patients with cirrhosis
by: Dae Gon Ryu, et al.
Published: (2024-09-01)

Prognostic factors for esophageal respiratory fistula in unresectable esophageal squamous cell carcinoma treated with radiotherapy
by: Jia-Chao Qi, et al.
Published: (2024-07-01)

Case report: Long-term survival in synchronous double primary malignancies of lung adenocarcinomas and esophageal squamous cell carcinoma treated with definitive chemoradiotherapy and SBRT combined with anti-PD-1
by: Rui Zeng, et al.
Published: (2025-02-01)

Association of effective dose to immune cells and vertebral marrow dose with hematologic toxicity during neoadjuvant chemoradiotherapy in esophageal squamous cell carcinoma
by: Meng Zhang, et al.
Published: (2024-06-01)

CT-based radiomics combined with hematologic parameters for survival prediction in locally advanced esophageal cancer patients receiving definitive chemoradiotherapy
by: Jinfeng Cui, et al.
Published: (2024-03-01)